financetom
Business
financetom
/
Business
/
Angel Oak Mortgage Prices $50 Million Debt Offering
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Angel Oak Mortgage Prices $50 Million Debt Offering
Jul 19, 2024 12:53 AM

03:37 AM EDT, 07/19/2024 (MT Newswires) -- Angel Oak Mortgage (AOMR) said Thursday that it has priced a public offering of $50 million worth of 9.500% senior notes due 2029.

The offering, expected to close July 25, is subject to the satisfaction of customary closing conditions.

The company said it plans to spend net proceeds from the offering for general corporate purposes, including the possible acquisition of non-qualified residential mortgage loans and other assets from its affiliated mortgage lending platform. The company may also use net proceeds from the offering to repurchase about $20 million of its shares from Xylem Finance, an affiliate of Davidson Kempner Capital Management.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Political storms won't curb military spending boom, defence firms say
Political storms won't curb military spending boom, defence firms say
Jul 24, 2024
FARNBOROUGH, England (Reuters) - Defence firms are confident Western governments will continue to increase spending on weapons to counter Russia and China, brushing off concerns that political upheaval in the United States and Europe could curb military budgets. Global defence spending hit a record $2.4 trillion last year, boosted by the war in Ukraine and rising tensions between China and...
Thermo Fisher lifts profit forecast as biotech demand shows signs of improvement
Thermo Fisher lifts profit forecast as biotech demand shows signs of improvement
Jul 24, 2024
(Reuters) - Thermo Fisher on Wednesday raised its annual profit outlook and posted a better-than-expected second-quarter profit, banking on improved demand for its tools and services used in clinical trials. Contract drug manufacturers witnessed cut back on spending by their biotech clients in 2023 amid rising interest rates. The public funding environment for early-stage biotechs is expected to improve in...
Quarterhill Awarded US$1.2 Million Maintenance Contract in South Dakota
Quarterhill Awarded US$1.2 Million Maintenance Contract in South Dakota
Jul 24, 2024
07:09 AM EDT, 07/24/2024 (MT Newswires) -- Quarterhill ( QTRHF ) said Wednesday that it won a US$1.2 million contract to provide maintenance, training, and emergency repair services for the South Dakota Department of Transportation (SDDOT) through December 2026. The contract includes the scheduled maintenance and operational support of the electronic screening (e-screening) systems at six weigh stations in the...
Boston Scientific Q2 Adjusted Earnings, Net Sales Rise; Raises 2024 Outlook
Boston Scientific Q2 Adjusted Earnings, Net Sales Rise; Raises 2024 Outlook
Jul 24, 2024
07:08 AM EDT, 07/24/2024 (MT Newswires) -- Boston Scientific ( BSX ) reported Q2 adjusted earnings Wednesday of $0.62 per diluted share, up from $0.53 a year earlier. Analysts polled by Capital IQ expected $0.58. Net sales for the quarter ended June 30 were $4.12 billion, up from $3.6 billion a year earlier. Analysts polled by Capital IQ expected $4.02...
Copyright 2023-2026 - www.financetom.com All Rights Reserved